Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period A Placebo-Controlled, Randomized Trial

被引:83
作者
Leucker, Thorsten M. [1 ]
Blaha, Michael J. [1 ]
Jones, Steven R. [1 ]
Vavuranakis, Michael A. [1 ]
Williams, Marlene S. [1 ]
Lai, Hong [2 ]
Schindler, Thomas H. [3 ]
Latina, Jacqueline [1 ]
Schulman, Steven P. [1 ]
Gerstenblith, Gary [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA
[3] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Nucl Med, St Louis, MO USA
关键词
acute coronary syndrome; cholesterol; LDL; evolocumab; secondary prevention;
D O I
10.1161/CIRCULATIONAHA.120.046320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:419 / 421
页数:3
相关论文
共 5 条
[1]   2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J].
Grundy, Scott M. ;
Stone, Neil J. ;
Bailey, Alison L. ;
Beam, Craig ;
Birtcher, Kim K. ;
Blumenthal, Roger S. ;
Braun, Lynne T. ;
de Ferranti, Sarah ;
Faiella-Tommasino, Joseph ;
Forman, Daniel E. ;
Goldberg, Ronald ;
Heidenreich, Paul A. ;
Hlatky, Mark A. ;
Jones, Daniel W. ;
Lloyd-Jones, Donald ;
Lopez-Pajares, Nuria ;
Ndumele, Chiadi E. ;
Orringer, Carl E. ;
Peralta, Carmen A. ;
Saseen, Joseph J. ;
Smith, Sidney C., Jr. ;
Sperling, Laurence ;
Virani, Salim S. ;
Yeboah, Joseph .
CIRCULATION, 2019, 139 (25) :E1082-E1143
[2]   Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) [J].
Koskinas, Konstantinos C. ;
Windecker, Stephan ;
Pedrazzini, Giovanni ;
Mueller, Christian ;
Cook, Stephane ;
Matter, Christian M. ;
Mueller, Olivier ;
Haner, Jonas ;
Gencer, Baris ;
Crljenica, Carmela ;
Amini, Poorya ;
Deckarm, Olga ;
Iglesias, Juan F. ;
Raber, Lorenz ;
Heg, Dik ;
Mach, Francois .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (20) :2452-2462
[3]   Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome [J].
Schwartz, G. G. ;
Steg, P. G. ;
Szarek, M. ;
Bhatt, D. L. ;
Bittner, V. A. ;
Diaz, R. ;
Edelberg, J. M. ;
Goodman, S. G. ;
Hanotin, C. ;
Harrington, R. A. ;
Jukema, J. W. ;
Lecorps, G. ;
Mahaffey, K. W. ;
Moryusef, A. ;
Pordy, R. ;
Quintero, K. ;
Roe, M. T. ;
Sasiela, W. J. ;
Tamby, J. -F. ;
Tricoci, P. ;
White, H. D. ;
Zeiher, A. M. ;
Aylward, Philip E. ;
Drexel, Heinz ;
Sinnaeve, Peter ;
Dilic, Mirza ;
Lopes, Renato D. ;
Gotcheva, Nina N. ;
Goodman, Shaun G. ;
Prieto, Juan-Carlos ;
Yong, Huo ;
Lopez-Jaramillo, Patricio ;
Pecin, Ivan ;
Reiner, Zeljko ;
Ostadal, Petr ;
Poulsen, Steen Hvitfeldt ;
Viigimaa, Margus ;
Nieminen, Markku S. ;
Danchin, Nicolas ;
Chumburidze, Vakhtang ;
Marx, Nikolaus ;
Liberopoulos, Evangelos ;
Montenegro Valdovinos, Pablo Carlos ;
Tse, Hung-Fat ;
Kiss, Robert Gabor ;
Xavier, Denis ;
Zahger, Doron ;
Valgimigli, Marco ;
Kimura, Takeshi ;
Kim, Hyo Soo .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22) :2097-2107
[4]   Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial [J].
Schwartz, GG ;
Olsson, AG ;
Ezekowitz, MD ;
Ganz, P ;
Oliver, MF ;
Waters, D ;
Zeiher, A ;
Chaitman, BR ;
Leslie, S ;
Stern, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (13) :1711-1718
[5]   Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy [J].
Wiviott, SD ;
Cannon, CP ;
Morrow, DA ;
Ray, KK ;
Pfeffer, MA ;
Braunwald, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) :1411-1416